NYSEAM:STXSMedical Equipment
Stereotaxis (STXS) Q1 2026 Loss Near US$6 Million Tests Bullish Margin Narrative
Stereotaxis (STXS) opened Q1 2026 with revenue of US$6.3 million and a net loss of US$6.2 million, equal to an EPS loss of US$0.06, as the stock trades around US$1.85. The company reported quarterly revenue of US$7.5 million in Q1 2025 and US$6.3 million in Q1 2026, while EPS loss moved from US$0.07 to US$0.06 over the same period. On a trailing twelve month basis, EPS loss was US$0.24 on revenue of US$31.2 million. Overall, the update keeps the focus on how revenue growth potential might...